Susan Spitzler, MD
Dermatology · Alpharetta, GANPI 1376652172
Payments from drug & device makers
Across 512 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Galderma Laboratories, L.p.$2K
- Sanofi$835
- Amgen$764
- Pfizer$563
- Biofrontera Inc.$548
- plus $3K from 25 others
What the payments were for
- Consulting fees$1,40014%
- Speaking & faculty fees$3504%
- Food & beverage$8,14382%
- Education$460%
- Gifts$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 192 | $2,412 |
| Galderma Laboratories, L.p. | 23 | $1,878 |
| Sanofi | 34 | $835 |
| Amgen | 55 | $764 |
| Pfizer | 42 | $563 |
| Biofrontera Inc. | 6 | $548 |
| Regeneron Healthcare Solutions, Inc. | 21 | $429 |
| Sun Pharmaceutical Industries Inc. | 15 | $298 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 15 | $265 |
| UCB, Inc. | 10 | $227 |
| Lilly USA, LLC | 10 | $202 |
| Novartis | 9 | $194 |
| Bristol Myers Squibb | 7 | $176 |
| LEO Pharma Inc. | 8 | $162 |
| Incyte Corporation | 22 | $152 |
| E.r. Squibb & Sons, L.L.C. | 4 | $110 |
| Dermavant Sciences, Inc. | 4 | $105 |
| Johnson & Johnson | 5 | $105 |
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| Strata Skin Sciences, Inc. | 7 | $83 |
| Botanix SB Inc | 3 | $62 |
| Almirall LLC | 2 | $53 |
| Organon | 3 | $44 |
| Boehringer Ingelheim | 2 | $43 |
| Hill Dermaceuticals, Inc. | 1 | $35 |
| Mayne Pharma Commercial LLC | 2 | $29 |
| Verrica Pharmaceuticals Inc. | 1 | $27 |
| Mylan Pharmaceuticals Inc. | 1 | $25 |
| Encore Dermatology Inc. | 1 | $19 |
| Mission Pharmacal Company | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,973 in reported general payments places this provider in the 75th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelaic Acid | 12 | $1,495 |
| Ketoconazole | 59 | $1,168 |
| Fluorouracil | 14 | $938 |
| Tacrolimus | 11 | $832 |
| ValacyclovirValacyclovir Hcl | 28 | $597 |
| Triamcinolone Acetonide | 88 | $558 |
| Fluocinolone Acetonide | 13 | $470 |
| Ciclopirox | 14 | $414 |
| Nystatin | 29 | $388 |
| Hydrocortisone | 41 | $240 |
| Mupirocin | 31 | $151 |
| Cephalexin | 14 | $119 |
| Minoxidil | 15 | $81 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Alpharetta
- Tiffani HamiltonAlpharetta$3.3M
- Chynna JohnsonAlpharetta$60K
- Anjali VekariaAlpharetta$25K
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.